Positive development. Good to see management quietly plugging away on their strategy. Fully funded after recent rights issue and management been buying additional stock on market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025